Diametric Capital, LP Beyond Spring Inc. Transaction History

Diametric Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.02 - $16.84 $110,369 - $462,342	-27,455 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$9.26 - $31.31 $697,305 - $2.36 Million	-75,303 Reduced 73.28%	27,455 $433,000
Q2 2021 Aug 16, 2021	SELL	$9.37 - $12.12 $109,254 - $141,319	-11,660 Reduced 10.19%	102,758 $1.07 Million
Q1 2021 May 17, 2021	BUY	$10.61 - $15.77 $1.21 Million - $1.8 Million	114,418 New	114,418 $1.27 Million

5.44M

30.3K

1.8K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $88.4M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Diametric Capital, LP with notifications on news.